Cardiovascular adverse outcomes following CIN
| Adverse event | Outcome: CIN group vs no CIN group |
|---|---|
| In-hospital mortality | 7.1% vs 1.1% (p<0.0000001) McCullough et al,25 n=1826 |
| 1 year mortality | 37.7% vs 19.4% (p=0.001) Gruberg et al,27 n=439 |
| Persistent worsening of renal function (eGFR>25% baseline at 3/12) | 18.6% vs 0.9% (p=0.0001) Maioli et al,28 n=1490 |
| Haemodialysis | 0.7% McCullough et al25 7% Gruberg et al27 |
CIN, contrast-induced nephropathy; CM, contrast media; eGFR, estimated glomerular filtration rate.